Tnf pharmaceuticals (formerly mymd pharmaceuticals) begins trading under new nasdaq stock symbol “tnfa” effective before market open today

Baltimore--(business wire)---- $mymd--tnf pharmaceuticals, inc. (nasdaq: tnfa) (formerly mymd pharmaceuticals, inc.) (the “company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases and autoimmune and inflammatory conditions, today announced that its common stock, listed on the nasdaq capital market, begins trading under the new ticker symbol, “tnfa,” effective before the market open today, july 24, 2024. the new trading symbol “tnfa” replaces t.
NDAQ Ratings Summary
NDAQ Quant Ranking